Dilara Jappar

406 total citations
13 papers, 322 citations indexed

About

Dilara Jappar is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Dilara Jappar has authored 13 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Dilara Jappar's work include Drug Transport and Resistance Mechanisms (3 papers), Phosphodiesterase function and regulation (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Dilara Jappar is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Phosphodiesterase function and regulation (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Dilara Jappar collaborates with scholars based in United States, Germany and France. Dilara Jappar's co-authors include David E. Smith, Yongjun Hu, Ke Ma, Kathleen M. Hillgren, Winston Thomas, Ann Corken Mackey, Joyce A. Korvick, Paul G. Kluetz, Richard F. Keep and Joseph A. Hrabie and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Langmuir and Pharmaceutical Research.

In The Last Decade

Dilara Jappar

8 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dilara Jappar United States 7 130 78 63 57 49 13 322
Ryutaro Adachi Japan 13 128 1.0× 232 3.0× 42 0.7× 48 0.8× 88 1.8× 26 583
Angela Wehr United States 11 86 0.7× 110 1.4× 49 0.8× 24 0.4× 24 0.5× 19 400
Thorsten Keller Germany 13 210 1.6× 174 2.2× 99 1.6× 91 1.6× 34 0.7× 23 495
Walter M. Williams United States 11 93 0.7× 80 1.0× 40 0.6× 47 0.8× 30 0.6× 18 371
P. Rolan United Kingdom 10 114 0.9× 62 0.8× 129 2.0× 18 0.3× 76 1.6× 14 619
How Sung Lee Singapore 10 110 0.8× 189 2.4× 42 0.7× 14 0.2× 20 0.4× 19 485
Ken-ichi Inui Japan 11 305 2.3× 109 1.4× 136 2.2× 81 1.4× 23 0.5× 16 448
Atsushi Ose Japan 10 346 2.7× 128 1.6× 182 2.9× 42 0.7× 14 0.3× 18 601
Catherine S. Temple United Kingdom 7 244 1.9× 150 1.9× 67 1.1× 133 2.3× 15 0.3× 10 350

Countries citing papers authored by Dilara Jappar

Since Specialization
Citations

This map shows the geographic impact of Dilara Jappar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilara Jappar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilara Jappar more than expected).

Fields of papers citing papers by Dilara Jappar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilara Jappar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilara Jappar. The network helps show where Dilara Jappar may publish in the future.

Co-authorship network of co-authors of Dilara Jappar

This figure shows the co-authorship network connecting the top 25 collaborators of Dilara Jappar. A scholar is included among the top collaborators of Dilara Jappar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilara Jappar. Dilara Jappar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yu, Yang, Masahiro Ishida, Dilara Jappar, & Donald F. Zoz. (2025). Effects of Itraconazole, a Strong CYP3A Inhibitor, on Pharmacokinetics of Nerandomilast, a Preferential PDE4B Inhibitor. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1772–A1772.
2.
Choi, Han Seok, et al.. (2025). Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Nerandomilast (Bi 1015550) in Participants With and Without Renal Impairment. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1767–A1767.
3.
Yu, Yang, et al.. (2025). Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Nerandomilast (BI 1015550) in Participants With and Without Hepatic Impairment. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1765–A1765.
4.
5.
6.
Jappar, Dilara, et al.. (2024). Impact of Chronic Inflammatory Diseases on Clinical Pharmacokinetics of Antibody‐Based Therapeutic Proteins. Clinical Pharmacology & Therapeutics. 117(3). 646–658. 1 indexed citations
7.
Mackey, Ann Corken, et al.. (2012). Accumulating Evidence for a Drug–Drug Interaction Between Methotrexate and Proton Pump Inhibitors. The Oncologist. 17(4). 550–554. 73 indexed citations
8.
Jappar, Dilara, Yongjun Hu, & David E. Smith. (2011). Effect of Dose Escalation on the In Vivo Oral Absorption and Disposition of Glycylsarcosine in Wild-Type and Pept1 Knockout Mice. Drug Metabolism and Disposition. 39(12). 2250–2257. 20 indexed citations
9.
10.
Jappar, Dilara, Yongjun Hu, Richard F. Keep, & David E. Smith. (2008). Transport Mechanisms of Carnosine in SKPT Cells: Contribution of Apical and Basolateral Membrane Transporters. Pharmaceutical Research. 26(1). 172–181. 27 indexed citations
11.
Smith, David E., et al.. (2008). Targeted Disruption of Peptide TransporterPept1Gene in Mice Significantly Reduces Dipeptide Absorption in Intestine. Molecular Pharmaceutics. 5(6). 1122–1130. 99 indexed citations
12.
13.
Jappar, Dilara, et al.. (2003). Micellar Catalysis of Nitric Oxide Dissociation from Diazeniumdiolates. Langmuir. 19(6). 2096–2102. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryutaro Adachi Breakdown of academic impact, for papers by Angela Wehr Breakdown of academic impact, for papers by Thorsten Keller Breakdown of academic impact, for papers by Walter M. Williams Breakdown of academic impact, for papers by P. Rolan Breakdown of academic impact, for papers by How Sung Lee Breakdown of academic impact, for papers by Ken-ichi Inui Breakdown of academic impact, for papers by Atsushi Ose Breakdown of academic impact, for papers by Catherine S. Temple
Rankless by CCL
2026